Webinar preview: Novonesis promotes mental health benefits of psychobiotics

20 May 2024 — In the continuously growing mental wellness market, Novonesis Human Health division is pinpointing the potential of a new class of biotics for mental wellness — “psychobiotics” — targeting the gut-brain axis. The company highlights the importance of clinically proven psychobiotic strains, with a sophisticated and demonstrated mode of action to satisfy consumer demand for multi-functional supplements addressing the multifaceted and interconnected dimensions of mental wellness. 

Science defines psychobiotics as “any exogenous influence — probiotics, prebiotics or dietary fiber — whose positive effect on mental health is bacterially mediated.”